Acrocephalosyndactyly
| Acrocephalosyndactyly | |
|---|---|
| Synonyms | Acrocephaly-syndactyly |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Craniosynostosis, syndactyly, intellectual disability |
| Complications | Hearing loss, vision problems, dental issues |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Clinical examination, genetic testing |
| Differential diagnosis | Crouzon syndrome, Pfeiffer syndrome |
| Prevention | None |
| Treatment | Surgery, occupational therapy, speech therapy |
| Medication | Pain management |
| Prognosis | Varies |
| Frequency | Rare |
| Deaths | Rarely directly |
Acrocephalosyndactyly is a rare genetic disorder that encompasses a group of conditions characterized by craniosynostosis and syndactyly. Craniosynostosis is the premature fusion of one or more cranial sutures, leading to an abnormal head shape. Syndactyly involves the fusion of two or more fingers or toes. This condition is part of a broader category of disorders known as craniofacial syndromes, which affect the skull and facial bones.
Etiology[edit]
Acrocephalosyndactyly is primarily caused by genetic mutations that affect the development of the bones in the skull and limbs. The most common genetic mutations associated with this condition occur in the FGFR (Fibroblast Growth Factor Receptor) genes. These mutations are usually inherited in an autosomal dominant pattern, meaning only one copy of the altered gene in each cell is sufficient to cause the disorder.
Classification[edit]
There are several types of Acrocephalosyndactyly, each with distinct characteristics:
- Apert Syndrome: Characterized by craniosynostosis, syndactyly of the hands and feet, and distinctive facial features.
- Crouzon Syndrome: Involves craniosynostosis, with no hand or foot abnormalities but with distinctive facial features.
- Pfeiffer Syndrome: Features craniosynostosis, broad thumbs and big toes, and partial soft tissue syndactyly.
- Saethre-Chotzen Syndrome: Includes craniosynostosis, facial asymmetry, ptosis (drooping of the upper eyelid), and mild syndactyly.
Symptoms[edit]
The symptoms of Acrocephalosyndactyly vary depending on the specific type but generally include:
- Abnormal head shape due to craniosynostosis
- Fused fingers or toes (syndactyly)
- Intellectual disability (varies by type and individual)
- Vision problems
- Hearing loss
- Breathing difficulties
- Dental problems
Diagnosis[edit]
Diagnosis of Acrocephalosyndactyly is based on physical examination, medical history, and imaging tests such as X-rays or CT scans to assess the extent of craniosynostosis and syndactyly. Genetic testing can confirm the diagnosis by identifying mutations in the FGFR genes or other genes associated with the condition.
Treatment[edit]
Treatment for Acrocephalosyndactyly is multidisciplinary and may involve:
- Surgery to correct craniosynostosis and reshape the skull
- Surgery to separate fused fingers or toes
- Orthodontic treatment for dental problems
- Management of vision and hearing problems
- Supportive therapies, such as physical therapy and occupational therapy
Prognosis[edit]
The prognosis for individuals with Acrocephalosyndactyly varies widely depending on the severity of the symptoms and the success of treatment interventions. Early diagnosis and treatment can improve outcomes, particularly in terms of cognitive development and quality of life.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian